Anmelden Kostenlos registrieren

Agile Therapeutics Inc EPS Q / Q

Was ist das EPS Q / Q von Agile Therapeutics Inc?

EPS Q / Q von Agile Therapeutics Inc ist -92.64%

Was ist die Definition von EPS Q / Q?



Die vierteljährliche EPS-Wachstumsrate, Quartal für Quartal , ist die Steigerung des EPS eines Unternehmens in den letzten vier Quartalen im Vergleich zu den Ergebnissen der vorangegangenen vier Quartale.

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS Q / Q von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Agile Therapeutics Inc

Was macht Agile Therapeutics Inc?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Unternehmen mit eps q / q ähnlich Agile Therapeutics Inc